Max Planck Institute researchers, led by Martin Thanbichler, have made a significant discovery in bacterial cell wall remodeling that could contribute to the development of new therapeutic strategies against bacterial infections. The study, focused on the bacterium Caulobacter crescentus, reveals the role of a central regulator called DipM, which controls different classes of autolysins, or lytic enzymes involved in cell wall remodeling.
Most bacterial species have a semi-rigid cell wall surrounding the cytoplasmic membrane, composed mainly of peptidoglycan. This cell wall provides protection and determines cell shapes. The constant remodeling of the cell wall, involving autolysins and peptidoglycan synthases, is essential for cell growth and division. The coordination of these activities is crucial to maintain cell integrity and prevent cell lysis and death.
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
DipM, a soluble periplasmic protein, was identified as a versatile regulator, interacting with several classes of autolysins and a cell division factor. Remarkably, DipM stimulates the activity of two peptidoglycan-cleaving enzymes with distinct activities and folding, making it the first regulator known to control two classes of autolysins. Disruption of DipM leads to the loss of regulation during cell wall remodeling and division, ultimately leading to cell death.
The findings of this study, published in Nature Communications, offer valuable insights into how cells respond to changes in their environment and open possibilities for new therapeutic approaches to combat bacteria by disrupting multiple autolytic pathways simultaneously. As many antibiotics target the bacterial cell wall, this research could pave the way for the development of more effective treatments against bacterial infections.